Cargando…
Pharmacological induction of pancreatic islet cell transdifferentiation: relevance to type I diabetes
Type I diabetes (T1D) is an autoimmune disease in which an immune response to pancreatic β-cells results in their loss over time. Although the conventional view is that this loss is due to autoimmune destruction, we present evidence of an additional phenomenon in which autoimmunity promotes islet en...
Autores principales: | Piran, R, Lee, S-H, Li, C-R, Charbono, A, Bradley, L M, Levine, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123101/ https://www.ncbi.nlm.nih.gov/pubmed/25077543 http://dx.doi.org/10.1038/cddis.2014.311 |
Ejemplares similares
-
PAR2 regulates regeneration, transdifferentiation, and death
por: Piran, Ron, et al.
Publicado: (2016) -
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
por: Lafferty, Ryan A., et al.
Publicado: (2021) -
Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation
por: Ren, Jiaqiang, et al.
Publicado: (2007) -
Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment
por: Mahoney, Alexandra L. G., et al.
Publicado: (2022) -
Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer
por: Goess, Ruediger, et al.
Publicado: (2021)